Cytomegalovirus-Specific Immunity Recovers More Slowly after Cord Blood Transplantation Compared with Matched Sibling Donor Allogeneic Transplantation.

Bejanyan, N; Vlasova-St Louis, I; Mohei, H; Cao, Q; El Jurdi, N; Wagner, J E; Miller, J S; Brunstein, C G

Bejanyan, N; Vlasova-St Louis, I; Mohei, H; Cao, Q; El Jurdi, N; Wagner, J E; Miller, J S; Brunstein, C G.

Afiliación

Bejanyan N; Department of Medicine. University of Minnesota, Minneapolis, Minnesota.
Vlasova-St Louis I; Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota.
Mohei H; Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota.
Cao Q; Biostatistics Core, Masonic Cancer Center. Adult and Pediatric Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, Minnesota.
El Jurdi N; Department of Medicine. University of Minnesota, Minneapolis, Minnesota.
Wagner JE; Division of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, MN.
Miller JS; Department of Medicine. University of Minnesota, Minneapolis, Minnesota.
Brunstein CG; Department of Medicine. University of Minnesota, Minneapolis, Minnesota.

Transplant Cell Ther ; 27(2): 187.e1-187.e4, 2021 Feb.

Article en En | MEDLINE | ID: mdl-33718897

Palabras clave

IFN-Î³ ELISpot; hematopoietic cell transplantation (HCT); immune reconstitution; matched sibling donor (MSD); umbilical cord blood (UCB)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Transplant Cell Ther Año: 2021 Tipo del documento: Article